Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 4, 2010, Pages 799-807

  Lishko, V K ^a   Yermolenko, I S ^a   Ugarova, T P ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Adhesion; Fibrin; Fibrinolysis; Integrins; Plasminogen; Thrombus

Indexed keywords

FIBRIN; PLASMINOGEN;

ARTICLE; BLOOD FLOW; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBRIN CLOT; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; THROMBOCYTE ADHESION;

ANTIFIBRINOLYTIC AGENTS; BLOOD PLATELETS; CELL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRIN; FIBRINOLYSIN; FIBRINOLYSIS; HEMORHEOLOGY; HUMANS; LEUKOCYTES; PLASMINOGEN; PLATELET ADHESIVENESS; TIME FACTORS; TRANEXAMIC ACID; U937 CELLS;

EID: 77952688395     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03778.x     Document Type: Article

References (41)

1. Kuijper PHM, Torres HIG, van der Linden JAM, Lammers JWJ, Sixma JJ, Zwaginga JJ, Koenderman L. Neutrophil adhesion to fibrinogen and fibrin under flow conditions is diminished by activation and L-selectin shedding. Blood 1997, 89:2131-8.
2. Kuijper PHM, Torres G, Lammers J-WJ, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood 1997, 89:166-75.
3. Hantgan RR, Endenburg SC, Cavero I, Marguerie G, Uzan A, Sixma JJ, de Groot PG. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by arg-gly-asp and fibrinogen gamma-chain carboxy terminal peptides. Thromb Haemost 1992, 68:694-700.
4. Arfors K-E, Dhall DP, Engeset J, Hint H, Matherson NA, Tangen O. Biolaser endothelial trauma as a means of quantifying platelet activity in vivo. Nature 1968, 218:887-8.
5. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973, 5:167-79.
6. Groves HM, Kinlough-Rathbone RL, Richardson M, Jorgensen L, Moore S. Thrombin generation and fibrin formation following injury to rabbit neointima. Lab Invest 1982, 46:605-12.
7. van Ryn J, Lorenz M, Merk H, Buchanan M, Eisert WG. Accumulation of radiolabeled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole. Thromb Haemost 2003, 90:1179-86.
8. Beygui F, Collet JP, Nagaswami C, Weisel JW, Montalescot G. Architecture of intracoronary thrombi in ST-elevation acute myocardial infarction. Time makes difference. Circulation 2006, 113:e21-3.
9. Yates SG, D'Sa A, Berger K, Fernandes LG, Wood SJ, Rittenhouse EA, Davis CC, Mansfield PB, Sauvage LR. The preclotting of porous arterial prostheses. Ann Surg 1978, 188:611-22.
10. Patel M, Arnell RE, Sauvage LR, Wu HD, Shi Q, Wechezak AR, Mungin D, Walker M. Experimental evaluation of ten clinically used arterial prostheses. Ann Vasc Surg 1992, 6:244-51.
11. van Aken PJ, Emeis JJ. Organization of experimentally induced arterial thrombosis in rats: the first six days. Artery 1982, 11:156-73.
12. McGuiness CL, Humphries J, Waltham M, Burnand KG, Collins M, Smith A. Recruitment of labelled monocytes by experimental venous thrombi. Thromb Haemost 2001, 85:1018-24.
13. Lishko VK, Burke T, Ugarova TP. Anti-adhesive effect of fibrinogen: a safeguard for thrombus stability. Blood 2007, 109:1541-9.
14. Endenburg SC, Lindeboom-Blokzijl L, Zwaginga JJ, Sixma JJ, de Groot PG. Plasma fibrinogen inhibits platelet adhesion in flowing blood to immobilized fibrinogen. Arterioscler Thromb Vasc Biol 1996, 16:633-8.
15. Podolnikova NP, Yermolenko IS, Fuhrmann A, Lishko VK, Magonov S, Bowen B, Enderlein J, Podolnikov A, Ros R, Ugarova TP. Control of integrin αIIbβ3 outside-in signaling and platelet adhesion by sensing the physical properties of fibrin(ogen) substrates. Biochemistry 2009, 49:68-77.
16. Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation influence of omega-aminocarboxylic acids. Biochim Biophys Acta 1975, 393:55-65.
17. Lucas MA, Fretto LJ, McKee PA. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 1983, 258:4249-56.
18. Suenson E, Lutzen O, Thorsen S. Initial plasmin-degradation of fibrin as a basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 1984, 140:513-22.
19. Tran-Thang C, Kruithof EK, Atkinson J, Bachmann F. High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin. Eur J Biochem 1986, 160:599-604.
20. Sakharov DV, Rijken DC. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995, 92:1883-90.
21. Sakharov DV, Nagelkerke JF, Rijken DC. Rearrangements of the fibrin network and spacial distribution of fibrinolytic components during plasma clot lysis. J Biol Chem 1996, 271:2133-8.
22. Sasajima T, Takano Y, Hiraishi Y, Goh K, Inaba M, Azuma N, Sasajima Y, Yamazaki K, Yamamoto H. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system. J Vasc Surg 2000, 32:374-82.
23. Plow EF, Redlitz A, Hawley SB, Xue S, Herren T, Hoover-Plow JL, Miles LA. Assembly of the plasminogen system on cell surfaces. Fibrinolytics and Antifibrinolytic 2000, 141-70. Bachmann F, In, ed, Berlin, Springer-Verlag
24. Ugarova TP, Budzynski AZ, Shattil SJ, Ruggeri ZM, Ginsberg MH, Plow EF. Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIa. J Biol Chem 1993, 268:21080-7.
25. Schober JM, Chen N, Grzeszkiewicz T, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SCT. Identification of integrin αMβ2 as an adhesion receptor on peripheral blood monocytes for Cyr61 and connective tissue growth factor, immediate-early gene products expressed in atherosclerotic lesions. Blood 2002, 99:4457-65.
26. Olson JD, Zaleski A, Herrimann D, Flood PA. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and risrocetin. J Lab Clin Med 1989, 14:6-18.
27. Ellis V, Behrendt N, Dano K. Cellular receptor for urokinase-type plasminogen activator: function in cell-surface proteolysis. Methods Enzymol 1993, 223:223-33.
28. TranThang C, Kruithof EKO, Bachman F. Tissue-type plasminogen activator increases the binidng of glu-plasminogen to clots. J Clin Invest 1984, 74:2009-16.
29. Fleury V, Angles-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 1991, 30:7630-8.
30. Takada A, Sugawara Y, Takada Y. Degradation of Glu- and Lys-plasminogen by elastase in the presence of absence of tranexamic acid. Thromb Res 1988, 50:285-94.
31. Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985, 260:4303-11.
32. Veklich Y, Francis CW, White J, Weisel JW. Structural studies of fibrinolysis by electron microscopy. Blood 1998, 12:4721-9.
33. Hashimoto Y, Kobayashi A, Yamazaki N, Sugawara Y, Takada Y, Takada A. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity. Thromb Res 1987, 46:625-33.
34. van den Eijnden-Schrauwen Y, Kooistra T, de Vries REM, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995, 85:3510-17.
35. Felez J, Chanquia CJ, Levin EG, Miles LA, Plow EF. Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood 1991, 78:2318-27.
36. Vaughan DE, Mendelsohn ME, Declerck PJ, van Houtte E, Collen D, Loscalzo J. Characterization of the binding of human tissue-type plasminogen activator to platelets. J Biol Chem 1989, 264:15869-74.
37. Vogel V, Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev 2006, 7:265-75.
38. Meltzer ME, Doggen CJM, de Groot PG, Rosendaal FR, Lisman T. Fibrinolysis and the risk of venous and arterial thrombosis. Curr Opin Hematol 2007, 14:242-8.
39. Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 2000, 95:577-80.
40. Zeng B, Bruce D, Kril J, Ploplis V, Frredman B, Brieger D. Influence of plasminogen deficiency on the contribution of polymorphonuclear leukocytes to fibrin/ogenolysis. Thromb Haemost 2002, 88:805-10.
41. Angles-Cano E, de la Pena Diaz A, Loyau S. Inhibition of fibrinolysis by lipoproteins(a). Ann NY Acad Sci 2001, 936:261-75.